← Back to headlines
Summit Therapeutics Focuses on Ivonescimab Trial for Non-Small Cell Lung Cancer
Summit Therapeutics Inc. is concentrating its efforts on the clinical trial of Ivonescimab, a drug being developed for the treatment of non-small cell lung cancer.
2 Mar, 07:56 — 2 Mar, 07:56
Sources
Showing 1 of 1 sources
Related Stories
UNICEF Report Finds 20 Million Children Annually Face Online Sexual Exploitation
43m ago
Genetically Modified Pig Kidney Keeps US Patient Alive for Record Nine Months
1h ago
Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops
3h ago
RFK Jr. Allegedly Requested Removal of Measles Deaths From CDC Tally
4h ago